Tag Archives: The Stem Cell Blog

Here’s What’s Driving Crispr Therapeutics AG Higher Today … – Madison.com

Continue reading

2018-01-23 NEWS

Madison.com

Here’s What’s Driving Crispr Therapeutics AG Higher Today …
Madison.com
Shares of Crispr Therapeutics AG (NASDAQ: CRSP), a start-up biotech using eponymous gene-editing technology to develop new therapies, popped 15.2% in early-morning trading on Tuesday. Shares have settled to a gain of 14.4% as of 12:10 p.m. EST after
Ipswich Investment Management Co. Inc. Takes $1.13 Million Position in Crispr Therapeutics AG (NASDAQ:CRSP)The Ledger Gazette
Shares that proliferate your speculations: CRISPR Therapeutics AG (CRSP)The News Journal
Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to BuyMarket Exclusive
Post Analyst –Norman Weekly –Aiken Advocate
all 25 news articles »
Continue reading

2018-01-23 NEWS

Norman Weekly

Here’s What’s Driving Crispr Therapeutics AG Higher Today
Motley Fool
In the U.S., Crispr Therapeutics and its peers are still awaiting regulatory reviews that would allow them to begin human testing with their first new therapy candidates. Perhaps fearing international condemnation for playing fast and loose with
Crispr Therapeutics (CRSP) Lifted to Buy at SunTrust BanksThe Ledger Gazette
Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to BuyMarket Exclusive
Stocks that can influence your investment – CRISPR Therapeutics AG (NASDAQ:CRSP)The News Journal
Post Analyst –Norman Weekly –TrueBlueTribune
all 24 news articles »
Continue reading

2018-01-23 NEWS

Norman Weekly

Here’s What’s Driving Crispr Therapeutics AG Higher Today
Motley Fool
In the U.S., Crispr Therapeutics and its peers are still awaiting regulatory reviews that would allow them to begin human testing with their first new therapy candidates. Perhaps fearing international condemnation for playing fast and loose with
Crispr Therapeutics (CRSP) Lifted to Buy at SunTrust BanksThe Ledger Gazette
Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to BuyMarket Exclusive
Stocks that can influence your investment – CRISPR Therapeutics AG (NASDAQ:CRSP)The News Journal
Post Analyst –Norman Weekly –Aiken Advocate
all 24 news articles »
Continue reading

2018-01-23 NEWS

Norman Weekly

Here’s What’s Driving Crispr Therapeutics AG Higher Today
Motley Fool
In the U.S., Crispr Therapeutics and its peers are still awaiting regulatory reviews that would allow them to begin human testing with their first new therapy candidates. Perhaps fearing international condemnation for playing fast and loose with
Crispr Therapeutics (CRSP) Lifted to Buy at SunTrust BanksThe Ledger Gazette
Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to BuyMarket Exclusive
Stocks that can influence your investment – CRISPR Therapeutics AG (NASDAQ:CRSP)The News Journal
Post Analyst –Norman Weekly –Aiken Advocate
all 24 news articles »
Continue reading

2018-01-23 NEWS

Science Magazine

Nobel laureate suggests he could fall on sword over colleague’s bogus paper
Science Magazine
The paper in question appeared in the journal Stem Cell Reports in March 2017. According to a report signed by Yamanaka posted on CiRA’s website, after receiving allegations of possibly fraudulent images, CiRA and Kyoto University started a preliminary

and more »